Lv1
40 积分 2025-04-15 加入
Glypican‐3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
10天前
已完结
Novel low‐avidity glypican‐3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC
12天前
已完结
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers
12天前
已完结
New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma
12天前
已完结
Immunotherapy for hepatocellular carcinoma: Recent advances and future targets
12天前
已完结
CAR-T therapy in solid tumors
12天前
已完结
Clinical investigation of CAR T cells for solid tumors: Lessons learned and future directions
20天前
已完结
CAR T cell therapy for patients with solid tumours: key lessons to learn and unlearn
22天前
已完结
Metabolic reprogramming in the tumor microenvironment of liver cancer
24天前
已完结
皖公网安备34019202002308
